Response to Szymczak et al. re: “A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion”
2023 · Thyroid · 0 citations
https://doi.org/10.1089/thy.2023.0325
A
Ayanthi Wijewardene
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
104
Citations
5
h-index
4
i10-index
Ayanthi Wijewardene is an academic researcher from University of Sydney. The author has contributed to research in topics: Thyroid Cancer Diagnosis and Treatment & Neuroendocrine Tumor Research Advances & Radiation Dose and Imaging. The author has an h-index of 5, co-authored 16 publications.
ORCID: 0000-0001-7868-1545Papers by this author
worksSupplementary Material for: Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre Experience
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14672832
The utility of 68Ga-DOTATATE and 18F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer
2025 · Thyroid Research · 0 citations
https://doi.org/10.1186/s13044-025-00250-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat